Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
FEBS J ; 289(14): 4251-4303, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-33934527

RESUMO

Vaccination is one of the greatest achievements in biomedical research preventing death and morbidity in many infectious diseases through the induction of pathogen-specific humoral and cellular immune responses. Currently, no effective vaccines are available for pathogens with a highly variable antigenic load, such as the human immunodeficiency virus or to induce cellular T-cell immunity in the fight against cancer. The recent SARS-CoV-2 outbreak has reinforced the relevance of designing smart therapeutic vaccine modalities to ensure public health. Indeed, academic and private companies have ongoing joint efforts to develop novel vaccine prototypes for this virus. Many pathogens are covered by a dense glycan-coat, which form an attractive target for vaccine development. Moreover, many tumor types are characterized by altered glycosylation profiles that are known as "tumor-associated carbohydrate antigens". Unfortunately, glycans do not provoke a vigorous immune response and generally serve as T-cell-independent antigens, not eliciting protective immunoglobulin G responses nor inducing immunological memory. A close and continuous crosstalk between glycochemists and glycoimmunologists is essential for the successful development of efficient immune modulators. It is clear that this is a key point for the discovery of novel approaches, which could significantly improve our understanding of the immune system. In this review, we discuss the latest advancements in development of vaccines against glycan epitopes to gain selective immune responses and to provide an overview on the role of different immunogenic constructs in improving glycovaccine efficacy.


Assuntos
COVID-19 , Neoplasias , Vacinas , COVID-19/prevenção & controle , Glicoconjugados/uso terapêutico , Humanos , Neoplasias/prevenção & controle , Polissacarídeos/uso terapêutico , SARS-CoV-2
2.
FEBS J ; 288(16): 4746-4772, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-33752265

RESUMO

Glycan structures are common posttranslational modifications of proteins, which serve multiple important structural roles (for instance in protein folding), but also are crucial participants in cell-cell communications and in the regulation of immune responses. Through the interaction with glycan-binding receptors, glycans are able to affect the activation status of antigen-presenting cells, leading either to induction of pro-inflammatory responses or to suppression of immunity and instigation of immune tolerance. This unique feature of glycans has attracted the interest and spurred collaborations of glyco-chemists and glyco-immunologists to develop glycan-based tools as potential therapeutic approaches in the fight against diseases such as cancer and autoimmune conditions. In this review, we highlight emerging advances in this field, and in particular, we discuss on how glycan-modified conjugates or glycoengineered cells can be employed as targeting devices to direct tumor antigens to lectin receptors on antigen-presenting cells, like dendritic cells. In addition, we address how glycan-based nanoparticles can act as delivery platforms to enhance immune responses. Finally, we discuss some of the latest developments in glycan-based therapies, including chimeric antigen receptor (CAR)-T cells to achieve targeting of tumor-associated glycan-specific epitopes, as well as the use of glycan moieties to suppress ongoing immune responses, especially in the context of autoimmunity.


Assuntos
Autoimunidade/imunologia , Polissacarídeos/imunologia , Receptores de Antígenos Quiméricos/imunologia , Linfócitos T/imunologia , Animais , Comunicação Celular/imunologia , Humanos , Nanopartículas/química , Polissacarídeos/química , Processamento de Proteína Pós-Traducional
3.
Mol Biol Rep ; 46(2): 1797-1808, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30734169

RESUMO

Selenium exhibits health-promoting properties in humans and animals. Therefore, the development of selenium-enriched dietary supplements has been growing worldwide. However, it may also exhibit toxicity at higher concentrations, causing increased oxidative stress. Different species of yeasts may exhibit different tolerances toward selenium. Therefore, in this study, we aimed to determine the effect of selenium on growth and on the antioxidative system in Candida utilis ATCC 9950 and Saccharomyces cerevisiae ATCC MYA-2200 yeast cells. The results of this study have demonstrated that high doses of selenium causes oxidative stress in yeasts, thereby increasing the process of lipid peroxidation. In addition, we obtained an increased level of GSSG from aqueous solutions of yeast biomass grown with selenium supplementation (40-60 mg/L). Increased levels of selenium in aqueous solutions resulted in an increase in the activity of antioxidant enzymes, including glutathione peroxidase and glutathione reductase. These results should encourage future research on the possibility of a thorough understanding of antioxidant system functioning in yeast cells.


Assuntos
Candida/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos dos fármacos , Selênio/metabolismo , Selênio/farmacologia , Antioxidantes/farmacologia , Candida/enzimologia , Candida/metabolismo , Proliferação de Células/efeitos dos fármacos , Suplementos Nutricionais , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos , Oxirredução , Estresse Oxidativo/efeitos dos fármacos , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/efeitos dos fármacos , Proteínas de Saccharomyces cerevisiae/metabolismo
4.
Electron. j. biotechnol ; 27: 25-31, May. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1010164

RESUMO

Background: Rhodotorula glutinis is capable of synthesizing numerous valuable metabolites with extensive potential industrial usage. This paper reports the effect of initial culture medium pH on growth and protein, lipid, and carotenoid biosynthesis by R. glutinis. Results: The highest biomass yield was obtained in media with pH 4.0­7.0, and the value after 72 h was 17.2­19.4 gd.w./L. An initial pH of the medium in the range of 4.0­7.0 has no significant effect on the protein (38.5­41.3 g/100 gd.w.), lipid (10.2­12.7 g/100 gd.w.), or carotenoid (191.7­202.9 µg/gd.w.) content in the biomass or on the profile of synthesized fatty acids and carotenoids. The whole pool of fatty acids was dominated by oleic (48.1­53.4%), linoleic (21.4­25.1%), and palmitic acids (13.0­15.8%). In these conditions, the yeast mainly synthesized torulene (43.5­47.7%) and ß-carotene (34.7­38.6%), whereas the contribution of torularhodin was only 12.1­16.8%. Cultivation in medium with initial pH 3.0 resulted in a reduction in growth (13.0 gd.w./L) and total carotenoid (115.8 µg/gd.w.), linoleic acid (11.5%), and torularhodin (4.5%) biosynthesis. Conclusion: The different values of initial pH of the culture medium with glycerol and deproteinized potato wastewater had a significant effect on the growth and protein, lipid, and carotenoid biosynthesis by R. glutinis.


Assuntos
Rhodotorula/metabolismo , Carotenoides/biossíntese , Leveduras , Solanum tuberosum , Proteínas/metabolismo , Biomassa , Águas Residuárias , Glicerol , Concentração de Íons de Hidrogênio , Lipídeos/biossíntese
5.
Electron. j. biotechnol ; 27: 44-48, May. 2017. tab
Artigo em Inglês | LILACS | ID: biblio-1010289

RESUMO

Background: Depletion of petroleum resources has enforced the search for alternative sources of renewable energy. Introduction of biofuels into the market was expected to become a solution to this disadvantageous situation. Attempts to cover fuel demand have, however, caused another severe problem­the waste glycerol generated during biodiesel production at a concentration of approximately 10% w/w. This, in turn, prompted a global search for effective methods of valorization of the waste fraction of glycerol. Results: Utilization of the waste fraction at 48 h with an initial glycerol concentration of 30 g·L-1 and proceeding with 62% efficiency enabled the production of 9 g·L-1 dihydroxyacetone at 50% substrate consumption. The re-use of the immobilized biocatalyst resulted in a similar concentration of dihydroxyacetone (8.7 g·L-1) in two-fold shorter time, with an efficiency of 85% and lower substrate consumption (35%). Conclusions: The method proposed in this work is based on the conversion of waste glycerol to dihydroxyacetone in a reaction catalyzed by immobilized Gluconobacter oxydans cell extract with glycerol dehydrogenase activity, and it could be an effective way to convert waste glycerol into a valuable product.


Assuntos
Células Imobilizadas/metabolismo , Di-Hidroxiacetona/metabolismo , Glicerol/metabolismo , Resíduos , Extratos Celulares , Células Imobilizadas/química , Gluconobacter oxydans , Biocombustíveis , Reciclagem , Energia Renovável , Glicerol/química
6.
Curr Pharm Biotechnol ; 18(2): 121-126, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28034292

RESUMO

BACKGROUND: Pullulan is a microbial polysaccharide of low energy value, which can component of low-calorie foods and in dietary snacks for diabetics. The objective of the study was to determine the effect of pullulan on the growth and fermentation activity of selected human intestinal bacteria. METHODS: Commercial pullulan purchased from Focubase (China) of a molecular weight of 100,000 Da constituted as experimental material. Food grade pullulan 99% purity. Two control media were prepared: the first standard RCM composed of (g/100 ml): 0.5 glucose, 0.1 soluble starch, 1.0 peptone, 1.0 meat extract, 0.3 yeast extract, 0.3 sodium acetate, 0.05 cysteine hydrochloride, 0.5 NaCl, pH 6.8; and the second modified RCM, wherein the soluble starch was replaced by increased glucose concentration to 2.0% (RCM+G). Experimental medium was the modified RCM medium, wherein the soluble starch and glucose were replaced by pullulan at a concentration of 2.0% (RCM+P). Stool suspensions were prepared from fresh stool samples (1 g) in peptone water (9 g), which were previously homogenized. Then, suspensions at a volume of 300 µl were transferred to the media (RCM, RCM+G, and RCM+P). After mixing, flasks were placed in anaerobic tubes with AnaeroGenTM 2.5 l sachets. Incubation of samples was carried out at 37°C for 48 h. RESULTS: The number of Bifidobacterium, Lactobacillus, and Escherichia coli bacteria, as well as pH and total acidity of the culture during 0, 24, and 48 h were measured. It was found that the numbers of bacteria of the Bifidobacterium and Lactobacillus genus in medium with pullulan were one logarithmic cycle lower in comparison to their numbers in the control media. Higher total acidity (1.48 g/100 ml) of pullulan culture in comparison to the control media was obtained (1.10 and 0.60 g/100 ml), and lower pH values than RCM medium, particularly 4.15 and 4.70, respectively. Pullulan exhibited selective effect on the natural microflora of the colon. Increase in the fermentation activity of bacteria in medium with pullulan favorably influenced modification of the composition of gut microbiota. CONCLUSION: In summary, pullulan exhibited a selective effect on the natural microflora of the infants' colon. Although no stimulating effect of pullulan on the growth of Bifidobacterium and Lactobacillus was observed, their increased acidifying activity, which probably was the cause of reduction in the number of E. coli bacteria, was confirmed.


Assuntos
Bifidobacterium/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Fezes/microbiologia , Microbioma Gastrointestinal/efeitos dos fármacos , Glucanos/farmacologia , Lactobacillus/efeitos dos fármacos , Bifidobacterium/crescimento & desenvolvimento , China , Colo/microbiologia , Escherichia coli/crescimento & desenvolvimento , Fezes/química , Fermentação , Glucanos/química , Humanos , Concentração de Íons de Hidrogênio , Lactente , Lactobacillus/crescimento & desenvolvimento , Peso Molecular
7.
Electron. j. biotechnol ; 19(4): 31-37, July 2016. ilus
Artigo em Inglês | LILACS | ID: lil-793950

RESUMO

Background: The exopolysaccharides (EPS) produced by yeast exhibit physico-chemical and rheological properties, which are useful in the production of food and in the cosmetic and pharmaceutical industries as well. The effect was investigated of selected carbon sources on the biosynthesis of EPS by Candida famata and Candida guilliermondii strains originally isolated from kefirs. Results: The biomass yields were dependent on carbon source (sucrose, maltose, lactose, glycerol, sorbitol) and ranged from 4.13 to 7.15 g/L. The highest biomass yield was reported for C. guilliermondii after cultivation on maltose. The maximum specific productivity of EPS during cultivation on maltose was 0.505 and 0.321 for C. guilliermondii and C. famata, respectively. The highest EPS yield was found for C. guilliermondii strain. The EPS produced under these conditions contained 65.4% and 61.5% carbohydrates, respectively. The specific growth rate (µ) of C. famata in medium containing EPS as a sole carbon source was 0.0068 h-1 and 0.0138 h-1 for C. guilliermondii strain. Conclusions: The most preferred carbon source in the synthesis of EPS for both Candida strains was maltose, wherein C. guilliermondii strain showed the higher yield of EPS biosynthesis. The carbon source affected the chemical composition of the resulting EPS and the contribution of carbohydrate in the precipitated preparation of polymers was higher during supplementation of maltose as compared to sucrose. It was also found that the EPS can be a source of carbon for the producing strains.


Assuntos
Polissacarídeos/biossíntese , Candida , Carboidratos , Carbono , Leveduras , Biomassa , Técnicas de Cultura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA